Dr. Reddy's Laboratories Limited (BOM:500124)
India
· Delayed Price · Currency is INR 1,195.35
+38.95 (3.37%)
At close: May 12, 2025
Dr. Reddy's Laboratories Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Net Income | 56,544 | 55,684 | 45,067 | 23,568 | 17,238 | Upgrade
|
| Depreciation & Amortization | 17,058 | 14,841 | 12,636 | 11,824 | 12,796 | Upgrade
|
| Loss (Gain) From Sale of Assets | -1,522 | -900 | 208 | -1,119 | 42 | Upgrade
|
| Asset Writedown & Restructuring Costs | 1,693 | 3 | 699 | 7,562 | 8,588 | Upgrade
|
| Loss (Gain) From Sale of Investments | -3,554 | -3,149 | -876 | -277 | -557 | Upgrade
|
| Loss (Gain) on Equity Investments | -217 | -147 | -370 | -703 | -480 | Upgrade
|
| Stock-Based Compensation | 424 | 407 | 397 | 592 | 584 | Upgrade
|
| Provision & Write-off of Bad Debts | 161 | 275 | 205 | 55 | 230 | Upgrade
|
| Other Operating Activities | 5,830 | -1,399 | 8,764 | 5,104 | 7,980 | Upgrade
|
| Change in Accounts Receivable | -10,283 | -8,054 | -5,752 | -17,012 | 2,081 | Upgrade
|
| Change in Inventory | -12,753 | -18,445 | -2,654 | -9,912 | -12,402 | Upgrade
|
| Change in Accounts Payable | 340 | 3,460 | 23 | 4,412 | 2,861 | Upgrade
|
| Change in Other Net Operating Assets | -7,293 | 2,857 | 528 | 4,014 | -3,258 | Upgrade
|
| Operating Cash Flow | 46,428 | 45,433 | 58,875 | 28,108 | 35,703 | Upgrade
|
| Operating Cash Flow Growth | 2.19% | -22.83% | 109.46% | -21.27% | 19.64% | Upgrade
|
| Capital Expenditures | -27,504 | -16,403 | -11,323 | -14,660 | -9,741 | Upgrade
|
| Sale of Property, Plant & Equipment | 512 | 1,064 | 82 | 370 | 85 | Upgrade
|
| Cash Acquisitions | -53,096 | - | - | -326 | -15,514 | Upgrade
|
| Sale (Purchase) of Intangibles | -6,162 | -11,011 | -7,543 | -1,443 | -2,820 | Upgrade
|
| Investment in Securities | 24,801 | -15,716 | -23,366 | -11,201 | 4,110 | Upgrade
|
| Other Investing Activities | 10,428 | 1,783 | 777 | 873 | 1,220 | Upgrade
|
| Investing Cash Flow | -51,021 | -40,283 | -41,373 | -26,387 | -22,660 | Upgrade
|
| Short-Term Debt Issued | 24,490 | 5,493 | - | 3,520 | 6,791 | Upgrade
|
| Long-Term Debt Issued | - | 3,800 | - | - | 3,800 | Upgrade
|
| Total Debt Issued | 24,490 | 9,293 | - | 3,520 | 10,591 | Upgrade
|
| Short-Term Debt Repaid | - | - | -19,382 | - | - | Upgrade
|
| Long-Term Debt Repaid | -1,294 | -4,947 | -1,015 | -785 | -4,497 | Upgrade
|
| Total Debt Repaid | -1,294 | -4,947 | -20,397 | -785 | -4,497 | Upgrade
|
| Net Debt Issued (Repaid) | 23,196 | 4,346 | -20,397 | 2,735 | 6,094 | Upgrade
|
| Issuance of Common Stock | 193 | 805 | 368 | 334 | 269 | Upgrade
|
| Repurchase of Common Stock | -1,389 | - | - | - | -1,193 | Upgrade
|
| Common Dividends Paid | -6,662 | -6,648 | -4,979 | -4,146 | -4,147 | Upgrade
|
| Other Financing Activities | -3,483 | -2,266 | -1,853 | -1,345 | -1,321 | Upgrade
|
| Financing Cash Flow | 11,855 | -3,763 | -26,861 | -2,422 | -298 | Upgrade
|
| Foreign Exchange Rate Adjustments | 224 | -59 | 286 | 733 | 113 | Upgrade
|
| Net Cash Flow | 7,486 | 1,328 | -9,073 | 32 | 12,858 | Upgrade
|
| Free Cash Flow | 18,924 | 29,030 | 47,552 | 13,448 | 25,962 | Upgrade
|
| Free Cash Flow Growth | -34.81% | -38.95% | 253.60% | -48.20% | 3.87% | Upgrade
|
| Free Cash Flow Margin | 5.81% | 10.40% | 19.34% | 6.27% | 13.68% | Upgrade
|
| Free Cash Flow Per Share | 22.68 | 34.83 | 57.16 | 16.17 | 31.22 | Upgrade
|
| Cash Interest Paid | 3,483 | 2,266 | 1,853 | 1,345 | 1,321 | Upgrade
|
| Cash Income Tax Paid | 19,993 | 20,047 | 10,714 | 7,437 | 5,716 | Upgrade
|
| Levered Free Cash Flow | 12,500 | 12,231 | 29,677 | 1,031 | 19,259 | Upgrade
|
| Unlevered Free Cash Flow | 14,268 | 13,301 | 30,569 | 1,629 | 19,865 | Upgrade
|
| Change in Net Working Capital | 16,144 | 15,765 | -2,770 | 17,281 | 1,680 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.